<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20140416017301N10</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-09-16</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Repetitive Facilitative Exercise Combined with Action Observation on Upper Limb Function in Stroke Patients</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Repetitive Facilitative Exercise (RFE) Combined with Action Observation (AO) on Upper Extremity Motor Function in Stroke Patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>10</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/93083</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Stroke.</hc_freetext>
      <i_freetext>Intervention group: All participants will receive a combined intervention consisting of Repetitive Facilitative Exercises and Action Observation for 6 weeks, three sessions per week, for a total of 18 sessions. Each session will last 45 minutes and will be delivered by the principal investigator. During the first 30 minutes of each session, Repetitive Facilitative Exercises will be performed to facilitate voluntary movement and improve motor function of the affected upper extremity. Participants will repeatedly perform targeted voluntary upper-extremity movements while the therapist simultaneously applies facilitative stimuli, including rapid stretch of the target muscle and rapid cutaneous stimulation. The exercises will involve the shoulder, elbow, wrist, and fingers. The subsequent 15 minutes of each session will be devoted to Action Observation. During this component, the participant will first observe a step-by-step video demonstration of a targeted upper-extremity movement or functional task and will then attempt to perform the same movement or task with the affected upper extremity according to his or her motor ability. The videos will be prepared by the researcher before the start of the study in accordance with the objectives and content of the intervention protocol and will include functional upper-extremity tasks such as reaching for objects, grasping, transferring, and releasing objects. The overall intervention framework will be identical for all participants; however, task selection, level of difficulty, amount of therapist assistance, and progression of training will be individually adjusted according to each participant’s motor status, response, and ability. Exercise intensity will also be modified according to the participant’s tolerance and clinical condition..</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Individual participant data will not be publicly shared because the current informed consent and ethics plan do not provide for public sharing of participant-level data. Study results will be reported only in aggregate form without identifying information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Akram Azad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation, Shahid Shahnazari Street, Madar Square, Mirdamad Blvd, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913187</zip>
        <telephone>+98 21 2222 8051</telephone>
        <email>azad.a@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Akram azad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation. Nazari Ave. Madar Sq. Mirdamad Blvd. Tehran City</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913187</zip>
        <telephone>+98 21 2222 8051</telephone>
        <email>azad.a@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis of ischemic or hemorrhagic stroke with upper extremity motor impairment (based on medical records and/or brain imaging).
Ability to maintain a stable sitting position for participation in training and assessment.
At least 3 months and a maximum of 5 years have passed since stroke onset.
Age between 30 and 75 years.
Being at Brunnstrom stage 3 or higher of upper extremity motor recovery.
Medical stability and ability to participate in the rehabilitation program.
Having a minimum cognitive function score of 22 based on the MoCA test.
Sufficient visual ability, with or without corrective aids, to observe video content
Written informed consent for participation in the study.
Education level: basic literacy (reading and writing)</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Severe contracture impairing limb movement
Comorbid chronic conditions, such as orthopedic, neurological, and metabolic disorders, addiction, and diabetes
Severe visual field defects or severe visuospatial neglect
Unilateral neglect
Receiving botulinum toxin injection in the affected upper extremity within 3 months before study entry
Decision to get a botulinum toxin injection during the intervention period</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I69</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Sequelae of cerebrovascular disease</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: All participants will receive a combined intervention consisting of Repetitive Facilitative Exercises and Action Observation for 6 weeks, three sessions per week, for a total of 18 sessions. Each session will last 45 minutes and will be delivered by the principal investigator. During the first 30 minutes of each session, Repetitive Facilitative Exercises will be performed to facilitate voluntary movement and improve motor function of the affected upper extremity. Participants will repeatedly perform targeted voluntary upper-extremity movements while the therapist simultaneously applies facilitative stimuli, including rapid stretch of the target muscle and rapid cutaneous stimulation. The exercises will involve the shoulder, elbow, wrist, and fingers. The subsequent 15 minutes of each session will be devoted to Action Observation. During this component, the participant will first observe a step-by-step video demonstration of a targeted upper-extremity movement or functional task and will then attempt to perform the same movement or task with the affected upper extremity according to his or her motor ability. The videos will be prepared by the researcher before the start of the study in accordance with the objectives and content of the intervention protocol and will include functional upper-extremity tasks such as reaching for objects, grasping, transferring, and releasing objects. The overall intervention framework will be identical for all participants; however, task selection, level of difficulty, amount of therapist assistance, and progression of training will be individually adjusted according to each participant’s motor status, response, and ability. Exercise intensity will also be modified according to the participant’s tolerance and clinical condition.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Motor function score of the affected upper extremity assessed by the upper extremity section of the Fugl-Meyer Assessment. Timepoint: Before the intervention at pre-test and after completion of the six-week intervention at post-test. Method of measurement: Upper extremity section of the Fugl-Meyer Assessment.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Upper extremity functional performance score based on the Action Research Arm Test. Timepoint: Before the intervention at pre-test and after completion of the six-week intervention at post-test. Method of measurement: Action Research Arm Test.</sec_outcome>
      <sec_outcome>Amount of use and quality of movement scores of the affected upper extremity in daily activities based on the Motor Activity Log. Timepoint: Before the intervention at pre-test and after completion of the six-week intervention at post-test. Method of measurement: Motor Activity Log.</sec_outcome>
      <sec_outcome>Upper extremity functional ability score based on the Chedoke Arm and Hand Activity Inventory-13 (CAHAI-13). Timepoint: Before the intervention at pre-test and after completion of the six-week intervention at post-test. Method of measurement: Chedoke Arm and Hand Activity Inventory (CAHAI-13).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Research Deputy, School of Rehabilitation Sciences, Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-08-18</approval_date>
        <contact_name>Research Ethics Committees Certificate</contact_name>
        <contact_address>School of Rehabilitation. Nazari Ave. Madar Sq. Mirdamad Blvd. Tehran City Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
